Table 3.
Non-Hodgkin's lymphoma and autoimmune diseases have similarities |
Provides information on chronic use |
Provides a large safety database of >370,000 patient exposures |
Provides 7 years of postmarketing experience |
Extensive experience allows us to predict and manage infusion reactions |
Low infection rate in oncology provides information on potential for infection in rheumatoid arthritis |